How peptides are built
A peptide links the small pieces used in proteins into a short chain. Insulin is one such substance.
That word describes the substance. It does not tell you how the finished product was made or reviewed.
The federal body responsible for reviewing medicine approvals is the Food and Drug Administration (FDA).
Open the source notes
Some are approved medicines
Semaglutide products Ozempic and Wegovy, plus tirzepatide products Mounjaro and Zepbound, have FDA approval as of September 26, 2026.
Their approved uses include blood-sugar control for type 2 diabetes and losing weight and keeping it off, depending on the product, as of September 26, 2026.
Those approvals are for named uses. They are not an approval of every peptide or every use of a drug.
Ask the person prescribing the medicine what the exact product is meant to treat in your case.
Open the source notes
Making it to order is different
Compounding prepares medicine for a patient's needs rather than supplying a ready-made product.
A compounded drug reaches patients without an FDA review of its quality, benefits or harms beforehand, as of September 26, 2026.
FDA describes preparation to order as one option if an approved medicine falls short of a patient's need, as of September 26, 2026.
A useful question is what need the change is meant to meet, and why an approved option does not meet it.
Open the source notes
A research label is a separate matter
As of September 26, 2026, FDA cautions against weight-loss products sold for human use despite labels saying they are for experiments. The quality of those products is unknown.
Treat research wording as a reason to pause the comparison and ask about the product's actual status.